Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

109 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Inflammation remains a dynamic component of portal hypertension in regressive alcohol-related cirrhosis.
Hofer BS, Simbrunner B, Königshofer P, Brusilovskaya K, Petrenko O, Taru V, Sorz-Nechay T, Zinober K, Regnat K, Semmler G, Lackner C, Trauner M, Mandorfer M, Schwabl P, Reiberger T. Hofer BS, et al. Among authors: simbrunner b. United European Gastroenterol J. 2024 Dec 21. doi: 10.1002/ueg2.12643. Online ahead of print. United European Gastroenterol J. 2024. PMID: 39708052 Free article.
Carvedilol vs. propranolol for the prevention of decompensation and mortality in patients with compensated and decompensated cirrhosis.
Fortea JI, Alvarado-Tapias E, Simbrunner B, Ezcurra I, Hernández-Gea V, Aracil C, Llop E, Puente A, Roig C, Reiberger T, García-Pagan JC, Calleja JL, Ferrero-Gregori A, Mandorfer M, Villanueva C, Crespo J. Fortea JI, et al. Among authors: simbrunner b. J Hepatol. 2024 Dec 17:S0168-8278(24)02772-7. doi: 10.1016/j.jhep.2024.12.017. Online ahead of print. J Hepatol. 2024. PMID: 39701300
Metabolomic profiles differentiate between porto-sinusoidal vascular disorder, cirrhosis, and healthy individuals.
Semmler G, Petrenko O, Lozano JJ, Shalaby S, Sánchez-Avila JI, Marella N, Hannich T, Wöran K, Balcar L, Simbrunner B, Lampichler K, Mozayani B, Trauner M, Mandorfer M, Reiberger T, García-Pagán JC, Scheiner B. Semmler G, et al. Among authors: simbrunner b. JHEP Rep. 2024 Sep 4;6(12):101208. doi: 10.1016/j.jhepr.2024.101208. eCollection 2024 Dec. JHEP Rep. 2024. PMID: 39624234 Free PMC article.
Letter: The Prognostic Role of IGF-1 in Chronic Liver Disease-Authors' Reply.
Hartl L, Schwarz M, Simbrunner B, Jachs M, Wolf P, Bauer DJM, Scheiner B, Balcar L, Semmler G, Hofer BS, Dominik N, Marculescu R, Trauner M, Mandorfer M, Reiberger T. Hartl L, et al. Among authors: simbrunner b. Aliment Pharmacol Ther. 2025 Jan;61(1):228-229. doi: 10.1111/apt.18368. Epub 2024 Nov 3. Aliment Pharmacol Ther. 2025. PMID: 39491332 No abstract available.
Diagnostic and prognostic performance of the LiverRisk score in tertiary care.
Semmler G, Balcar L, Simbrunner B, Hartl L, Jachs M, Schwarz M, Hofer BS, Fritz L, Schedlbauer A, Stopfer K, Neumayer D, Maurer J, Gensluckner S, Scheiner B, Aigner E, Trauner M, Reiberger T, Mandorfer M. Semmler G, et al. Among authors: simbrunner b. JHEP Rep. 2024 Jul 23;6(11):101169. doi: 10.1016/j.jhepr.2024.101169. eCollection 2024 Nov. JHEP Rep. 2024. PMID: 39444411 Free PMC article.
Hepatocellular Cancer Surveillance in Patients with Advanced Chronic Liver Disease.
Gu W, de Lédinghen V, Aubé C, Krag A, Strassburg C, Castéra L, Dumortier J, Friedrich-Rust M, Pol S, Grgurevic I, Zeleke Y, Praktiknjo M, Schierwagen R, Klein S, Francque S, Gottfriedová H, Sporea I, Schindler P, Rennebaum F, Brol MJ, Schulz M, Uschner FE, Fischer J, Margini C, Wang W, Delamarre A, Best J, Canbay A, Bauer DJM, Simbrunner B, Semmler G, Reiberger T, Boursier J, Rasmussen DN, Vilgrain V, Guibal A, Zeuzem S, Vassord C, Vonghia L, Šenkeříková R, Popescu A, Berzigotti A, Laleman W, Thiele M, Jansen C, Trebicka J. Gu W, et al. Among authors: simbrunner b. NEJM Evid. 2024 Nov;3(11):EVIDoa2400062. doi: 10.1056/EVIDoa2400062. Epub 2024 Oct 22. NEJM Evid. 2024. PMID: 39437136
Letter: Zinc and Selenium-Potential Biomarkers for Chronic Liver Disease? Authors' Reply.
Dominik N, Balcar L, Semmler G, Simbrunner B, Schwarz M, Hofer BS, Hartl L, Jachs M, Scheiner B, Pinter M, Trauner M, Mandorfer M, Pilger A, Reiberger T. Dominik N, et al. Among authors: simbrunner b. Aliment Pharmacol Ther. 2024 Nov;60(10):1497-1498. doi: 10.1111/apt.18324. Epub 2024 Oct 9. Aliment Pharmacol Ther. 2024. PMID: 39380454 No abstract available.
Bile acid metabolism and signalling in liver disease.
Fuchs CD, Simbrunner B, Baumgartner M, Campbell C, Reiberger T, Trauner M. Fuchs CD, et al. Among authors: simbrunner b. J Hepatol. 2025 Jan;82(1):134-153. doi: 10.1016/j.jhep.2024.09.032. Epub 2024 Sep 28. J Hepatol. 2025. PMID: 39349254 Free article. Review.
Aetiology-specific inflammation patterns in patients and rat models of compensated cirrhosis.
Hofer BS, Simbrunner B, Königshofer P, Brusilovskaya K, Petrenko O, Taru V, Sorz T, Zinober K, Semmler G, Kauschke SG, Pfisterer L, Trauner M, Mandorfer M, Schwabl P, Reiberger T. Hofer BS, et al. Among authors: simbrunner b. Dig Liver Dis. 2024 Sep 28:S1590-8658(24)01005-3. doi: 10.1016/j.dld.2024.09.006. Online ahead of print. Dig Liver Dis. 2024. PMID: 39343656 Free article.
Insulin-like growth factor-1 in cirrhosis is linked to hepatic dysfunction and fibrogenesis and predicts liver-related mortality.
Hartl L, Schwarz M, Simbrunner B, Jachs M, Wolf P, Bauer DJM, Scheiner B, Balcar L, Semmler G, Hofer BS, Dominik N, Marculescu R, Trauner M, Mandorfer M, Reiberger T. Hartl L, et al. Among authors: simbrunner b. Aliment Pharmacol Ther. 2025 Jan;61(1):88-98. doi: 10.1111/apt.18289. Epub 2024 Sep 21. Aliment Pharmacol Ther. 2025. PMID: 39305115 Free PMC article.
109 results